FDA campaign H-0526-2026
Class IIIHazard
Product contains undeclared cyclamates.
Distribution
NY, PA, FL, LA, TX
REKALLD area-alert coverage: FL, LA, NY, PA, TX (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.